Price Prediction

Coherent (COHR) Stock Price Prediction: Earnings beat and analyst resets keep the tape in play

Coherent (COHR) is trading around $223.90 after a sharp post-earnings rebound, with November 4 fiscal Q1 results showing $2.37 billion in revenue and non-GAAP EPS of $2.09. The move has held despit...

Coherent (COHR) Stock Price Prediction: Earnings beat and analyst resets keep the tape in play

What moved COHR

Coherent (COHR) has been re-rated by the market after a strong first-quarter fiscal 2027 report on November 4, 2026, when the company posted revenue of $2.37 billion, up 50% year over year, and non-GAAP EPS of $2.09, both ahead of expectations cited by Investing.com. The same report showed non-GAAP gross margin at 40.6% and management raised its fiscal 2027 outlook, including second-quarter revenue guidance of $2.55 billion to $2.75 billion and a full-year pro forma revenue growth target above 60%, which helps explain why shares have stayed bid into mid-November. citeturn0search0turn0search1

The stock also had support from analyst activity. Rosenblatt cut its price target to $400 from $500 on November 5 while keeping a Buy rating, and AlphaStreet reported that Citigroup, Rosenblatt, and Needham all maintained Buy ratings after adjusting targets lower, even as the shares surged 11.0% on November 11. Stockanalysis, citing 26 analysts polled by S&P Global, showed a consensus Buy rating with an average target of $371.92, a low target of $228, and a high of $524.96. citeturn0search2turn0search3

Technical structure: rebound, but not a clean breakout

At $223.90, COHR is trading above its 7-day SMA of $219.10 and 20-day SMA of $211.11, which supports the near-term recovery view. But the 50-day SMA sits higher at $246.93, so the stock is still working through a larger downtrend overlay rather than confirming a full trend reversal. The pivot at $217.80 is the level to watch for near-term trend health, while immediate resistance is $234.75 and stronger resistance is $245.59. citeturn0search4

Momentum is mixed rather than decisive. The 14-day RSI is 50.47, which is neutral, and the MACD histogram is flat at 0.0000, so the bounce is not yet paired with strong momentum confirmation. Bollinger positioning also leaves room to stretch higher, with the upper band at $242.10 and the middle band at $211.11. The daily ATR of $23.76 says volatility remains elevated, so wide intraday swings are still normal for this name. citeturn0search4

Derivatives: long positioning, but not a clean endorsement

Binance perpetual futures data is constructive on balance but not uniformly bullish. The global long/short ratio is 1.5387, with Binance global accounts 60.6% long and 39.4% short, and top-trader accounts are even more skewed at 70.2% long versus 29.8% short. That said, the 8-hour funding rate is flat at 0.0000%, open interest is down 14.82% over 24 hours to $5.67 million in daily open interest value, and taker buy/sell is 0.8673, which points to more aggressive selling than buying in the latest flow. citeturn0search4

That combination matters: crowded long ratios can support price in the short run, but falling open interest and negative taker flow suggest some traders are reducing exposure rather than pressing the breakout. In other words, the futures tape is supportive, but it is not a clean confirmation of sustained upside on its own. citeturn0search4

Key levels to watch

Immediate support is $206.96, followed by stronger support at $190.01. If COHR holds above the pivot at $217.80 and reclaims $234.75 with volume, the next technical test is $242.10 to $245.59. Failure to hold above the pivot would weaken the recovery narrative and reopen the lower support band. Volume is an important qualifier here: the current move is running at only 0.36x of the 5-day average, so the rally still needs stronger participation to look durable. citeturn0search4

Bottom line for traders

COHR has real fundamental backing from a strong fiscal Q1 beat and raised guidance, and that is the core reason the stock has been able to absorb lower analyst targets and still trend higher. But the chart is not pristine: the stock is below the 50-day average, momentum is neutral, and derivatives flow shows de-risking even as long ratios stay elevated. The cleanest read is that COHR remains in a recovery phase, not a confirmed breakout phase. citeturn0search0turn0search2turn0search4

Sign in to save this article Free account: build your research collection and return to read it anytime.